Staley Capital Advisers Inc. Sells 5,048 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Staley Capital Advisers Inc. cut its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 52.7% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 4,534 shares of the company's stock after selling 5,048 shares during the quarter. Staley Capital Advisers Inc.'s holdings in Henry Schein were worth $314,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. ING Groep NV acquired a new position in Henry Schein during the 3rd quarter valued at about $63,226,000. Holocene Advisors LP bought a new position in shares of Henry Schein in the third quarter valued at approximately $58,319,000. Southpoint Capital Advisors LP increased its stake in shares of Henry Schein by 30.0% during the third quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company's stock valued at $189,540,000 after acquiring an additional 600,000 shares during the period. Healthcare of Ontario Pension Plan Trust Fund bought a new stake in Henry Schein during the third quarter worth approximately $43,740,000. Finally, Bank of Montreal Can lifted its position in Henry Schein by 365.6% in the third quarter. Bank of Montreal Can now owns 711,487 shares of the company's stock worth $52,095,000 after purchasing an additional 558,689 shares during the period. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts have recently commented on the company. Jefferies Financial Group boosted their price objective on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research note on Thursday, January 23rd. UBS Group reduced their price objective on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research report on Wednesday, February 26th. Barrington Research reaffirmed an "outperform" rating and issued a $90.00 price target on shares of Henry Schein in a report on Wednesday, February 26th. Mizuho assumed coverage on Henry Schein in a research report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 target price on the stock. Finally, Bank of America raised Henry Schein from an "underperform" rating to a "buy" rating and lifted their price target for the stock from $69.00 to $84.00 in a research note on Monday, January 6th. Six investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $81.10.

Remove Ads

Henry Schein Stock Up 1.1 %

Shares of HSIC traded up $0.77 during mid-day trading on Friday, hitting $70.58. 1,443,065 shares of the company's stock were exchanged, compared to its average volume of 1,502,346. The stock has a market cap of $8.76 billion, a price-to-earnings ratio of 29.05, a P/E/G ratio of 2.13 and a beta of 0.90. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.49. The firm has a fifty day moving average of $74.81 and a two-hundred day moving average of $72.60. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter last year, the company posted $0.66 EPS. The business's revenue was up 5.8% compared to the same quarter last year. On average, sell-side analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.